OncNGS
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace
  • Home
  • Call for tenders (closed)
  • About OncNGS
  • Phases
    • Pre-commercial Procedure
    • Phase 0 : Curiosity Driven Research
    • Open Market Consultation
    • Phase I : Solution design
    • Phase II: Prototype development
    • Phase III : Clinical validation of a limited set of pre-commercial devices
  • FAQ
  • News
  • Contact
  • Workspace

Update on the current stage of the oncNGS Pre-Commercial Procurement procedure

Update on the current stage of the oncNGS Pre-Commercial Procurement procedure
2023-02-28
by Editorial team
Share us on:

Articles récents

  • Special Communication on oncNGS PCP published in ESMO Open
  • OncNGS enters Phase 3 of the PCP with two innovative solutions for cancer NGS testing
  • oncNGS consortium conducted site visits to phase 2 contractors
  • OncNGS has entered in prototyping phase (Phase 2) with the selection of three innovative approaches for future Next-Generation Sequencing (NGS) tests for cancer
  • Update on the current stage of the oncNGS Pre-Commercial Procurement procedure

Archives

  • mai 2025
  • janvier 2025
  • mai 2024
  • septembre 2023
  • février 2023
  • juillet 2022
  • juin 2022
  • mars 2022
  • janvier 2022
  • décembre 2021
  • novembre 2021
  • septembre 2021
  • août 2021
  • juin 2021
  • mai 2021
  • avril 2021
  • mars 2021

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874467

Follow us:

© OncNGS

  • Privacy policy
  • Disclaimer